Fresenius Medical Care AG (FMS) Capital Expenditures (2009 - 2025)

Fresenius Medical Care AG's Capital Expenditures history runs 17 years deep, the most recent figure standing at -$486.6 million for Q4 2025.

• In Q4 2025, Capital Expenditures fell 95.42% year-over-year to -$486.6 million; the TTM figure through Dec 2025 stood at -$1.1 billion (down 41.96% YoY), while the FY2025 annual figure was -$1.0 billion, down 42.96% from the prior year.
• Capital Expenditures was -$486.6 million for Q4 2025 at Fresenius Medical Care AG, down from -$166.4 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of -$140.1 million in Q1 2024 to a low of -$486.6 million in Q4 2025.
• Historically, Capital Expenditures has averaged -$208.9 million across 5 years, with a median of -$180.3 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Capital Expenditures surged 33.03% in 2022, then tumbled 95.42% in 2025.
• A 5-year view of Capital Expenditures shows it stood at -$307.7 million in 2021, then soared by 33.03% to -$206.1 million in 2022, then fell by 24.78% to -$257.1 million in 2023, then advanced by 3.18% to -$249.0 million in 2024, then tumbled by 95.42% to -$486.6 million in 2025.
• The last three Capital Expenditures figures came in at -$486.6 million (Q4 2025), -$166.4 million (Q2 2025), and -$149.4 million (Q1 2025), per Business Quant data.